NCT07014657Completed
Effect of Digital Combined Decongestive Therapy in Patients With Breast Cancer-related Lymphedema: a Follow-up Study
Source: ClinicalTrials.gov · Last updated 11 Jun 2025
Brief summary (registry, in English)
This study investigated the short- and long-term effects of digital combined decongestive therapy in breast cancer-related lymphedema. Limb volume and quality of life (Lymph-ICF) were assessed at baseline, post-treatment, and 12-week follow-up.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 29 (actual)
- First submitted
- 3 Jun 2025
- Start date
- 10 Jan 2018
- Primary completion date
- 5 Jan 2024
- Lead sponsor
- Bezmialem Vakif University
- Diseases
- Childhood cancers
- NCT number
- NCT07014657
What you commit to
- Study type: Interventional
- Participants enrolled: 29
- From 10 Jan 2018 to the primary completion date, 5 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of active infection.
- History of bilateral breast surgery.
- Severe breast cancer-related lymphedema.
Who the study is looking for
- Diagnosed with breast cancer-related lymphedema (BCRL) within the last 6 to 60 months.
- Voluntarily agreed to participate in the study.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bezmialem Vakıf University Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.